Trial
NCT02087241
Ph II Trial of Carboplatin and Pemetrexed With or Without AZD1775 for Untreated Lung Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
AstraZeneca
Collaborators
—
Condition
Previously Untreated Stage IV Non-Squamous Non Small Cell Lung Cancer
Intervention
AZD1775
Why stopped
The sponsor decided to terminate the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-29